Partner randomized controlled trial: Study protocol and coaching intervention

Department of Pediatrics, Division of Allergy and Pulmonary Medicine, Washington University, St Louis, MO 63110, USA.
BMC Pediatrics (Impact Factor: 1.93). 04/2012; 12(1):42. DOI: 10.1186/1471-2431-12-42
Source: PubMed


Many children with asthma live with frequent symptoms and activity limitations, and visits for urgent care are common. Many pediatricians do not regularly meet with families to monitor asthma control, identify concerns or problems with management, or provide self-management education. Effective interventions to improve asthma care such as small group training and care redesign have been difficult to disseminate into office practice.
This paper describes the protocol for a randomized controlled trial (RCT) to evaluate a 12-month telephone-coaching program designed to support primary care management of children with persistent asthma and subsequently to improve asthma control and disease-related quality of life and reduce urgent care events for asthma care. Randomization occurred at the practice level with eligible families within a practice having access to the coaching program or to usual care. The coaching intervention was based on the transtheoretical model of behavior change. Targeted behaviors included 1) effective use of controller medications, 2) effective use of rescue medications and 3) monitoring to ensure optimal control. Trained lay coaches provided parents with education and support for asthma care, tailoring the information provided and frequency of contact to the parent's readiness to change their child's day-to-day asthma management. Coaching calls varied in frequency from weekly to monthly. For each participating family, follow-up measurements were obtained at 12- and 24-months after enrollment in the study during a telephone interview. The primary outcomes were the mean change in 1) the child's asthma control score, 2) the parent's quality of life score, and 3) the number of urgent care events assessed at 12 and 24 months. Secondary outcomes reflected adherence to guideline recommendations by the primary care pediatricians and included the proportion of children prescribed controller medications, having maintenance care visits at least twice a year, and an asthma action plan. Cost-effectiveness of the intervention was also measured.
Twenty-two practices (66 physicians) were randomized (11 per treatment group), and 950 families with a child 3-12 years old with persistent asthma were enrolled. A description of the coaching intervention is presented.

Download full-text


Available from: Jane M Garbutt, Oct 02, 2015
1 Follower
11 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: To demonstrate the assessment of measurement invariance property in a health status instrument and to increase the awareness of its importance, we evaluate the measurement invariance of the Asthma Control Questionnaire (ACQ) across age and gender subgroups. Data are obtained from children 7-12 years of age at entry into a randomized trial, which evaluates the effect of a telephone coaching program on improving asthma outcome. Multi-group confirmatory factor analysis is used to assess the comparability of factor loadings and intercepts across age and gender subgroups. Since age is a continuous variable, two different categorizations (7-10 vs 11-12 and 7-9 vs 10-12) are analyzed. The factor loadings and intercepts of all six items in ACQ are comparable across gender subgroups. Although the factor loadings are comparable across age 7-10 and 11-12 subgroups, one intercept is statistically but not practically different. For age 7-9 versus 10-12 subgroup comparison, the factor loadings are not comparable. In children, the ACQ can be used to compare asthma control construct between boys and girls and between age 7-10 and 11-12 subgroups. Measurement invariance is an important property that should be examined when the latent construct(s) are compared across different subgroups.
    Quality of Life Research 07/2013; 23(2). DOI:10.1007/s11136-013-0474-x · 2.49 Impact Factor
  • Annals of allergy, asthma & immunology: official publication of the American College of Allergy, Asthma, & Immunology 12/2014; 114(2). DOI:10.1016/j.anai.2014.10.023 · 2.60 Impact Factor